Cargando…
Malignant syndrome in Parkinson's disease without dopaminergic drug withdrawal
Malignant syndrome is a rare complication occurring during the course of drug treatment for Parkinson's disease. It resembles neuroleptic malignant syndrome and is characterized by fever, marked rigidity, altered consciousness, leucocytosis and elevated creatine kinase. Malignant syndrome is a...
Autor principal: | Chandran, C. J. Suresh |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771991/ https://www.ncbi.nlm.nih.gov/pubmed/19893683 http://dx.doi.org/10.4103/0972-2327.44562 |
Ejemplares similares
-
Implications of dopaminergic medication withdrawal in Parkinson’s disease
por: Koschel, J., et al.
Publicado: (2021) -
Malignant Syndrome or Withdrawal Reaction?
Publicado: (2016) -
Interferon alfa–induced sarcoidosis resolving without drug withdrawal
por: Ortiz Salvador, José María, et al.
Publicado: (2016) -
Nivolumab-Induced Bullous Pemphigoid Managed without Drug Withdrawal
por: Munera-Campos, Mónica, et al.
Publicado: (2020) -
Carisoprodol withdrawal syndrome resembling neuroleptic malignant syndrome: Diagnostic dilemma
por: Paul, Gunchan, et al.
Publicado: (2016)